Literature DB >> 6487976

What has happened to perforated peptic ulcer?

R M Watkins, A R Dennison, J Collin.   

Abstract

The number of elective operations for chronic peptic ulceration has decreased substantially with the widespread use of H2-receptor antagonists. We have reviewed all cases of perforated peptic ulcer in Oxford over the last 18 years (1965-82) to see if a similar change in the incidence of this major complication of peptic ulceration has occurred. Since 1976 there has been a fall in the incidence of perforated peptic ulcer from 8.7 to 6.9 cases per 100 000 population per year. The male to female ratio decreased over the review period from 4.9:1 to 1.9:1 owing to a reduced incidence of perforation in men and an increased incidence in women. The mean age of men with perforated duodenal ulcer increased from 52.3 years in 1965-70 to 59.0 years in 1977-82. One hundred and sixty-six patients treated between 1977 and 1982 have been reviewed in detail. The overall mortality in this 6 year period was 12.7 per cent with an operative mortality rate of 8.9 per cent. The majority of perforations (65 per cent) are now of acute ulcers and therefore are unlikely to be prevented by improved therapy for chronic peptic ulceration.

Entities:  

Mesh:

Year:  1984        PMID: 6487976     DOI: 10.1002/bjs.1800711012

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  20 in total

1.  Changing trends in acute peptic ulcer surgery in a district surgical unit.

Authors:  M C Barry; Y Gul; M G Davies; D Long; M F Shine; F Lennon
Journal:  Ir J Med Sci       Date:  1996 Apr-Jun       Impact factor: 1.568

Review 2.  Asymptomatic peptic ulcer disease. Is it worth looking for?

Authors:  R Corinaldesi; R De Giorgio; A Paternicò; V Stanghellini
Journal:  Drugs       Date:  1991-06       Impact factor: 9.546

Review 3.  Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence.

Authors:  J G Williams; S E Roberts; M F Ali; W Y Cheung; D R Cohen; G Demery; A Edwards; M Greer; M D Hellier; H A Hutchings; B Ip; M F Longo; I T Russell; H A Snooks; J C Williams
Journal:  Gut       Date:  2007-02       Impact factor: 23.059

4.  Surgeons' attitudes to the operative management of duodenal ulcer perforation and haemorrhage.

Authors:  M D Stringer; A E Cameron
Journal:  Ann R Coll Surg Engl       Date:  1988-07       Impact factor: 1.891

5.  A multifactorial analysis of factors related to lethality after treatment of perforated gastroduodenal ulcer. 1935-1985.

Authors:  C Svanes; H Salvesen; B Espehaug; O Søreide; K Svanes
Journal:  Ann Surg       Date:  1989-04       Impact factor: 12.969

6.  High gastric ulcer.

Authors:  H E Jensen; J Hoffmann; P Wille-Jørgensen
Journal:  World J Surg       Date:  1987-06       Impact factor: 3.352

7.  Perforated duodenal ulcers.

Authors:  J Boey; J Wong
Journal:  World J Surg       Date:  1987-06       Impact factor: 3.352

8.  Perforated peptic ulcer in South India: an institutional perspective.

Authors:  Sankar Arveen; Sadasivan Jagdish; Dharanipragada Kadambari
Journal:  World J Surg       Date:  2009-08       Impact factor: 3.352

9.  Duodenal ulcer perforation: the effect of H2 antagonists?

Authors:  P Gillen; W Ryan; A L Peel; H B Devlin
Journal:  Ann R Coll Surg Engl       Date:  1986-09       Impact factor: 1.891

10.  Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration.

Authors:  C P Armstrong; A L Blower
Journal:  Gut       Date:  1987-05       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.